Hello
Supporting CAR-T Therapies: Innovation to Overcome Bioanalytical Challenges
There are many bioanalytical challenges that accompany development of cell therapies such as CAR-T therapies – which is why we are focused on continually refining and innovating our methods to address those complexities. Learn how we leverage platforms like qPCR, flow cytometry, and ELISpot to meet the specificity, selectivity, and sensitivity requirements of each unique study.
